Diabetic subjects diagnosed through the Diabetes Prevention Trial-type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset

Diabetes Care

Volumn 32, Issue 5, 2009, Pages 769-773

  Triolo, Taylor M ^a   Chase, H Peter ^a   Barker, Jennifer M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC KETOACIDOSIS; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; ONSET AGE; ORAL GLUCOSE TOLERANCE TEST; PRESCHOOL CHILD; SCHOOL CHILD; SCREENING TEST; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AUTOANTIBODIES; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; FAMILY; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ISLETS OF LANGERHANS; MALE; MASS SCREENING; MIDDLE AGED; NUCLEAR FAMILY; RANDOM ALLOCATION; REFERENCE VALUES; YOUNG ADULT;

EID: 65949083333     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1872     Document Type: Article

References (24)

1. Libman I, Songer T, LaPorte R. How many people in the U.S. have IDDM? Diabetes Care 1993;16:841-842
2. Songer TJ, LaPorte R, Lave JR, Dorman JS, Becker DJ. Health insurance and the financial impact of IDDM in families with a child with IDDM. Diabetes Care 1997;20:577-584 (Pubitemid 27143418)
3. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW, Hutton JC. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007;104:17040-17045 (Pubitemid 350210987)
4. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996;45:926-933 (Pubitemid 26225509)
5. Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Bottazzo GF, Gale EAM. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 1997;46:1701-1710 (Pubitemid 27456400)
6. Allen C, Palta M, D'Alessio DJ. Risk of diabetes in siblings and other relatives of IDDM subjects. Diabetes 1991;40:831-836
7. Rewers A, Klingensmith G, Davis C, Petitti DB, Pihoker C, Rodriguez B, Schwartz ID, Imperatore G, Williams D, Dolan LM, Dabelea D. Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study. Pediatrics 2008;121:e1258-e1266
8. Wolfsdorf J, Glaser N, Sperling MA. Diabetic ketoacidosis in infants, children, and adolescents: a consensus statement from the American Diabetes Association. Diabetes Care 2006;29:1150-1159 (Pubitemid 44115263)
9. Barker JM, Goehrig SH, Barriga K, Hoffman M, Slover R, Eisenbarth GS, Norris JM, Klingensmith GJ, Rewers M. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care 2004;27:1399-1404 (Pubitemid 38679990)
10. Diabetes Prevention Trial-Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002;346:1685-1691
11. Skyler JS, Krischer JP, Wolfsdorf J, Cowie C, Palmer JP, Greenbaum C, Cuthbertson D, Rafkin-Mervis LE, Chase HP, Leschek E. Effects of oral insulin in relatives of patients with type 1 diabetes: the Diabetes Prevention Trial-Type 1. Diabetes Care 2005;28:1068-1076
12. Greenbaum CJ, Cuthbertson D, Krischer JP. Type 1 diabetes manifested solely by 2-h oral glucose tolerance test criteria. Diabetes 2001;50:470-476 (Pubitemid 32127306)
13. Bingley PJ, Colman P, Eisenbarth GS, Jackson RA, McCulloch DK, Riley WJ, Gale EAM. Standardization of IVGTT to predict IDDM. Diabetes Care 1992;15:1313-1316
14. Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS, The Diabetes Prevention Trial-Type 1 Study Group. Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care 2006;29:643-649
15. Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, Glaser NS, Hanas R, Hintz RL, Levitsky LL, Savage MO, Tasker RC, Wolfsdorf JI. European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics 2004;113:e133-e140
16. Levy-Marchal C, Papoz L, de Beaufort C, Doutreix J, Froment V, Voirin J, Czernichow P. Clinical and laboratory features of type I diabetic children at time of diagnosis. Diabet Med 1992;9:279-284
17. Komulainen J, Lounamaa R, Knip M, Kaprio EA, Akerblom HK. Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function: Childhood Diabetes in Finland Study Group. Arch Dis Child 1996;75:410-415
18. Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 2004;53:250-264
19. Pozzilli P, Visalli N, Buzzetti R, Cavallo MG, Marietti G, Hawa M, Leslie RD. Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: a population-based study: IMDIAB Study Group: immunotherapy diabetes. Metabolism 1998;47:1205-1210
20. Knip M, Ilonen J, Mustonen A, Akerblom HK. Evidence for an accelerated B-cell destruction in HLA-Dw3/Dw4 heterozygous children with type I (insulin-dependent) diabetes. Diabetologia 1986;29:347-351 (Pubitemid 16060891)
21. Snorgaard O, Lassen LH, Binder C. Homogeneity in pattern of decline of β-cell function in IDDM: prospective study of 204 consecutive cases followed for 7.4 yr. Diabetes Care 1992;15:1009-1013
22. Steffes MW, Sibley S, Jackson M, Thomas W. β-Cell function and the development of diabetes-related complications in the Diabetes Control and Complications Trial. Diabetes Care 2003;26:832-836 (Pubitemid 36929351)
23. Hummel M. Psychological impact of childhood islet autoantibody testing in families participating in the BABYDIAB study. 2004;21:324-328 (Pubitemid 38519666)
24. Ross LF. Minimizing risks: the ethics of predictive diabetes mellitus screening research in newborns. Arch Pediatr Adolesc Med 2003;157:89-95 (Pubitemid 36347803)